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Abstract: 

Hypoxia is a condition of inadequate oxygen supply. Adaptive responses can be 
developed by cells that undergo hypoxic conditions. To understand human hypoxic responses, 
our lab generated a human hypoxic neuronal cell model system using the hypoxic mimicking 
compound, Desferoxamine (DFO), to simulate hypoxic condition. We found that DFO treatment 
decreased cell viability. However, some cells still survived. Using confocal image analysis the 
surviving cells were morphologically similar to control (vehicle-treated) cells. These surviving 
cells developed the adaptive responses, such as the decrease ofhuman mu opioid receptor 
(hMOR) message level and the increase of hypoxia inducible factor I (HIP-I) mRNA level by 
RT-PCR analysis. Additionally the level ofhuman delta opioid receptor (hDOR) message was 
not changed, whereas, the human kappa opioid receptor (hKOR) message level was up regulated 
in these surviving neurons. Therefore, this study was to first investigate if hKOR protein levels 
increased under hypoxia. The results of radioisotope ligand binding-assay showed that 48 hour 
DFO treatment resulted in the increase ofhKOR protein levels. To further examine if the HIF 
response element located at the hKOR promoter region was responsible for the increase of 
hKOR message level, four putative HIF-I response elements from the hKOR gene were cloned 
into the pGL3-promoter vector, a plasmid containing the luciferase reporter gene. Using transient 
transfection with human Neuorblastoma (NMB) cells, the preliminary results showed that several 
HIF responsive elements are involved in the up-regulation ofhKOR message under DFO 
simulated hypoxic condition. 
VI 
Introduction 

Hypoxia: 
Oxygen is essential for cell survival; therefore, tissue oxygenation is essential for all 
nonnal physiological functions, including but not limited to, cell growth, respiration, and 
metabolism. However, medical conditions such as cardiac arrest, asthma, pneumonia, and stroke 
cause the body to be deprived ofadequate oxygen or a condition called hypoxia. Additionally, 
hiking at high altitudes, diving underwater, and extensive athletic training can cause hypoxic 
conditions in the body. In tum, hypoxia can be defined as the deficiency in the bioavailability of 
oxygen to the tissues of the body (Loiacono, et aI., 2010). Connett and colleagues define in 
theory three thresholds ofcell hypoxia (Connett et aI., 1990). 
1. The first threshold is when cellular oxygen decreases but adenosine triphosphate (ATP) 
production is maintained at level sufficient to match ATP demand by metabolic adaptation. 
2. The second occurs when steady state A TP turnover can be maintained only by the production 
ofATP from anaerobic glycolysis by the Embden-Meyerhofpathway. This pathway generates 
only 2 molecules of ATP per 1 molecule of glucose metabolized. For highly metabolic tissues 
such as the kidney, liver, and brain, anaerobic glycolysis is too cumbersome to be effective and 
these organs develop A TP depletion rapidly under hypoxic conditions. 
3. The last threshold is when glycolysis becomes insufficient to produce enough ATP to maintain 
cell function and structural integrity. 
Many tissues after the second threshold develop ATP depletion. One of these tissues is 
the brain; nerve cells in the brain require high levels ofA TP to operate the sodium-potassium 
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pump. When 50-60% ofATP is lost due the decrease levels of oxygen, depolarization of the 
membrane and uptake of sodium and water occurs (Loiacono et aI., 2010). Depolarization results 
in an influx in calcium through voltage-gated calcium channels, and leads to glutamate 
neurotransmitter release (Cook et aI, 2010). Glutamate binds to glutamate receptors, initiating a 
process ofcalcium influx and excitatory injury called the glutamate cascade (Dendorfer et al., 
2005). The death of neurons from these insults can follow quickly in by swelling and lysing, or 
through a complex process resembling apoptosis (Dendorfer et aI., 2005). However, many 
studies have shown that some neuronal cells under hypoxic conditions do survive (Cook et aI., 
2010). These surviving cells develop adaptive responses, and express high levels ofhypoxia 
inducible factor 1a (HIF-1a) (Chavez et aI., 2006), which is a transcription factor and a major 
regulator of the cellular response to hypoxia (Semenza, 2000). 
Hypoxia Inducible Factor 1 (HIF-l) 
In mammalian cells, HIF -1 has been shown to play an essential role in the cellular and 
systemic oxygen homeostasis (Lee et aI., 2003). HIF -1 has been considered to be a master 
transcriptional regulator in hypoxia (Yan et aI., 2011) and be a key modulator for the induction 
ofgenes that facilitate adaption and survival of cells (Ke et aI., 2006). The genes targeted by 
HIF-1 include vascular endothelial growth factor (VEGF) that is involved in angiogenesis 
(Conway et al., 2001), insulin-like growth factors (IGF) (Krishnamachary et aI., 2003), and 
transforming growth factors (TGF) (Semenza, 2003). These genes can activate signal 
transduction pathways, which lead to cell proliferation and survival (Lee et aI., 2003). 
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HIF-l is a heterodimer complex that consists ofa hypoxic inducible subunit HIF-la and 
a constitutively expressed subunit HIF -I ~ also known as the aryl hydrocarbon receptor nuclear 
translocator (ARNT) (Ke et aI., 2006, Lee et aI., 2003). These proteins belong to the basic helix­
loop-helix- Per-ARNT-Sim (bHLH-PAS) protein family (Wang et aI., 1995). HIF-la subunit 
stability can be affected by oxygen levels. The a subunit contains two PAS and bHLH domains~ 
which are required for heterodimerzing of alpha and beta subunits and for binding to DNA (Lee 
et aI., 2003). It also contains two transactivation domains N-terminal (N-TAD) and C-terminal 
(C-TAD). The C-TAD terminal has been shown to interact with CBP/p300 coactivators to 
activate gene transcription (Ke et aI., 2006, Le et aI., 2003). 
The other important domain that mediates oxygen regulated stability is the oxygen­
dependent degradation domain (ODDD) (Pugh et aI., 1997). During normal conditions, HIF -1a 
has a short half-life of 5 minutes. In normoxia, hydroxylation of two proline residues Pro 402, 
and Pro 564 within the ODDD regions mediated by prolyl4-hydroxylase (PHD) (Masson et aI., 
2001), and the acetylation of lysine residue Lys 532 by acetyl transferase arrest-defective-l 
(ARD1) promote the interaction with an ubiquitin E3 ligase complex Von Hippel-Lindau 
(pVHL) (Jeong et aI., 2002). This in-tum marks HIF-la for degradation by the 26S proteasome. 
At the same time, the hydroxylation ofasparagine residue Asn 803 in the C-T AD of HIF-1 a by 
FIH-l prevents the interaction ofHIF-la to CBP/p300 (Lando et aI., 2002). 
However, during a hypoxic condition, activities ofPHD and FIH-l are inhibited, which 
results in no proline and asparagine hydoroxylation. Thus, there is no VHL binding and HIF-la 
is stabilized. HIF-la translocates to the nucleus and forms a heterodimer with HIF-I~, which 
then recruits CBP/p300 co-activators and enhances the gene transcription. These targets genes 
are related to erythropoiesis/iron metabolism, angiogenesis, vascular tone, glucose metabolism, 
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cell proliferation/survival, and apoptosis (Lee et aI., 2003; Ke et aI., 2006; Jeong et aI., 2002). 
HIF-l plays a major role in oxygen sensing system that governs cellular response to decrease 
levels ofoxygen (Schoolmeesters et aI., 2012). 
In previous studies, HIF-l has been shown to offer protection to neuronal cells under 
hypoxic insult using animal model systems. In the ischemic rat brain, HIP-l increased VEGF 
gene expression, which then increased blood-brain barrier permeability, and may offer 
neuroprotection (Yan et aI., 2011). In astrocytes of rats, an increase ofHlF-l increased glucose 
uptake (Valle-Casuso et aI., 2012). By exposing 14 day old embryonic mice to hyoxia­
reperfusion injury, HIF-lu provided neuronal protection (Vangeison et aI., 2008). Moreover, 
using the hypoxic pre-conditional mouse model, the induction ofHIF-l and its target genes 
offered therapeutic potential (Ferriero, 2005). 
Therefore, to study the hypoxic response ofhuman neurons, human neuroblastoma cell 
lines are commonly used as models (Jogi et aI., 2004). In the human NMB cells, hypoxia 
stabilizes HIF-lu proteins and activates expression of known hypoxic induced genes, such as 
erythropoietin, VEGF, IGF, TGF which are associated with cell metabolism or cell 
proliferation/survival (Mannello et al., 2011; Krishnamachary et aI., 2003; LeCouter et aI., 
2001). 
Previously, we generated a hypoxic cell model system, using human neuronal NMB cells 
with the hypoxic mimicking compound desferoxamine (DFO) (Cook et aI., 2010). 
Approximately 60% ofneuronal cells survived under chemically induced hypoxic conditions 
(Figure 1) (Cook et aI., 2010). Using annexin-V-FLUOS and propidium iodide staining (Figure 
2), the surviving cells did not show any significant morphological change as compared to the 
control cells using confocal microscopy analysis. This proves that cells were not at the apoptotic 
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or necrotic stages (Cook et aI., 2010). Furthermore, using RT-PCR, HIF-1 rnRNA levels 
increased after 24 hours (Figure 3) (Cook et aI., 2010). These data demonstrated that surviving 
neuronal cells did develop the adaptive responses, and can be used as a human hypoxic cell 
model system. 
Opioid Receptors: 
The NMB cell line also contains various types ofopioid receptors, which have been 
suggested to playa role in neuronal cell death and survival (Tegeder et aI., 2004). In mammalian 
cells there are three types of opioid receptors Mu, Kappa, and Delta (Waldhower et aI., 2004). 
They are G protein coupled receptors embedded in the plasma membrane of neurons 
(Waldhower et aI., 2004). When receptors are bound by a ligand, the associated G protein is 
activated and further activates the 2nd messenger systems (Minami et aI., 1995), which then can 
alter protein phosphorylation via the kinases and/or alter gene transcription (Waldhower et aI., 
2004). 
Previous studies have shown that treatment with Delta opioid receptor (DOR) agonist 
enkephalin led to neuroprotection in hypoxic conditions (Ma et aI., 2005). Treatment with Kappa 
opioid receptor (KOR) agonist U-50488 offered neuroprotective effects to mice in ischemic 
environment (Schunk et aI., 2011), and preconditioning with Mu opioid receptor (MOR) agonist 
morphine reduced neuronal death of rat cells in ischemic condition (Zhao et aI., 2006). However, 
there are also opposite results found in the literature. It has been shown that DOR agonist did not 
offer protection against moderate and mild ischemia in rat brain (Iwata et aI., 2007). 
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Furthermore, MOR and KOR did not protect neocortical neurons against ischemic injury (Zhang 
2000). 
In addition, opioid receptors are also known to modulate the sense ofpain (Schunk et aI., 
2011; Zhao et aI., 2006). Stroke, trauma, and cardiac arrest cause hypoxic conditions and can 
also cause pain in the body (Schunk et aI., 2011). Therefore, using the human neuronal NMB 
hypoxic model system, our lab also found that there was a reduction ofMOR mRNA message 
compared to the control (Figure 4A), and no significant changes were observed for DOR mRNA 
expression (Figure 4B) using RT-PCR (Cook et al., 2010). In addition, KOR mRNA expression 
showed a significant increase in the surviving cells (Karch et al., lab unpublished data). These 
results indicated; that opioid receptors may have a role in cell survival. 
Hypoxic mimicking compound 
To generate hypoxic condition, cells can be incubated in a hypoxic chambers or the usage 
of chemical compounds that induces hypoxic mimic conditions. These compounds include 
ophenanthroline, iodochlorohydroxyquinoline, cobalt sulfate heptahydrate, and DFO (Xia et aI., 
2009; Ryter et aI., 2000; Saini et al., 2009). DFO has been commonly used in hypoxia related 
research, and it is an iron chelator; it chelates the iron in the PHD region ofHIF-la that is 
loosely bound by 2-histidine-l-carboxylate coordination motif. By diminishing the availability of 
iron, HIF-la is stabilized because the prolyl-4-hydorxylase requires oxygen, iron and ascoarbate 
as cofactors (Ke et al., 2006); therefore, DFO can activate downstream responses similar to 
hypoxic condition (Bartolome et aI., 2008). In animal models, DFO induced hypoxia-like 
adaptive changes in the host (Dendorfer et aI., 2005; Hamrick et aI., 2005; Prass K et aI., 2002). 
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DFO has been shown to increase HIF-la expression in mice and rats neuronal cells (Jaakkola et 
aI., 2001; Pichiule et aI., 2007). 
Goal 
Our previous studies using NMB hypoxic model system have shown an increase ofHIF­
la mRNA levels, and an increase in hKOR messenger level using RT -peR analysis. This study 
is therefore to investigate if (1) the change of mRNA level resulted in the changes of protein 
levels of opioid receptors, and (2) ifHIF-la mediated the mRNA change ofhKOR in the same 
cell model system. 
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Figure 1: The effect ofDFO NMB cells, cel1s were treated with DFO in 2, 4, and 24hrs, and cell 
viability and GST levels were measured (Cook et ai., 2010). 
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Figure 2: Surviving cells were stained with annexin V-FLUOS and propidium iodide; the cell 
images were taken using confocal microscope under lOX or 40X magnification (Cook et aI., 
2010). 
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Figure 3: RT-PCR analysis ofHIF-l, expression ofHIF-l mRNA is increased under DFO 
treatment (Cook et aI., 2010). 
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Figure 4: RT-PCR analysis of the three human opioid receptors. A Mu opioid receptor mRNA 
expression, B. Delta opioid receptor mRNA expression. Quantitative analysis ofopioid 
expression is presented as mean ± S. E (Cook et aI., 2010). 
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Methods and Materials: 

Cell Culture: 
Human Neuroblastoma cells were grown in Roswell Park Memorial Institute Medium (RPM!) 
1640 containing 10% heat inactivated Fetal Bovine Serum (FBS). The cells were cultivated in 
tissue culture flasks (Fisher Scientific, Tunsitn, CA) in an atmosphere of 5% C02 and 95% air at 
37°C incubator. 
Plasmid Construction: 
The region containing the potential IDF response element were generated by PCR using Imin at 
95°C, 30 sec at 60°C and 30 sec at 72°C. The PCR products were then cloned into pCR2.1 vector 
(Life Technologies, Grand Island, NY). The inserts with correct sequences were then sublconed 
into pGL3 promoter vector (Promega, Madison, WI) that contains a luciferase reporter gene. The 
subcloned plasmids were then digested using Xhol and Asp718 (Promega, Madison, WI) to 
verify the presence of the insert. The plasm ids containing correct sequences were then used for 
further study. 
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Transient Transfection: 
Cells were plated in 6 well plates and then were transiently transfected using Effectene 
Transfection reagent (QIAGEN, Valencia, CA). Twenty-four hours after transfection, cells were 
treated with 300 J!M DFO for 24 hours treatments. After treatment cells harvested and lysed with 
lysis buffer (Promega, Madison, WI). Luciferase activity was determined following 
manufacturer procedure (Promega, Madison, WI) using luminometer (Berthold). 
Membrane Preparation: 
Cells were harvested with PBSIEDT A and then homogenized in 25 mM HEPES, pH 7.4, 
containing 0.32 M sucrose, and protease inhibitors phenylmethylsulfonylflurodie (PMSF), 
sodium orthovanadate, aprotinin, and pepstatin. Celllysates were then centrifuged at 3000 rpm 
for 10 minutes at 4°C, and supernatant was collected. Next, supernatant was centrifuged at 
24,000 rpm for 60 minutes at 4°C, The pellet was resuspended in 25mM HEPES, pH 7.4 and was 
ready for use. The protein concentration was determined using Lowry assay. 
Radioisotope Ligand Binding-Assay: 
Cell membranes (400 ug) were incubated with the H3 diprenorphine in the absence or presence 
of 1 J!M unlabeled opioid agonists- Mu-Damgo, Delta-Daddle, and Kappa-U-50 in 25 mM 
HEPES buffer, pH 7.4 for 60 minutes at room temperature in a final volume of 1 ml. The 
reaction was stopped by filtration through filters. The filters were washed two times with 1 ml of 
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cold 25 mM HEPES. pH 7.4. Then the filters were equilibrated with ScintiVerse-BD (Fisher. 
Tunsiten. CA) before assaying in the beta counter. 
14 

Results 

Examining the protein expression of hKOR in NMB cells 
Previously, in our lab DFO induced hypoxic mimic responses were investigated using the 
human neuronal NMB cell lines (Cook et aI., 2010). Using this cell model system, we found that 
some neuronal cells survived under DFO treatment, and the level ofHIF messages was 
increased, and the hMOR messages were also decreased in these surviving cells (Cook et aI., 
2010). RT-PCR analysis further showed an increase ofhKOR mRNA expression in these 
surviving NMB cells (Karch et aI., unpublished data). Therefore, the logical next step was to 
examine if hKOR protein levels also increased under the treatment. 
The receptor-ligand binding-assay was then carried out using the membrane preparations 
from NMB cells with the radioisotope-labeled ligand, 2nM H3-dipemorphine, 1 J.1M U-50488 as 
the cold competitive ligand. There are three opioid receptors, mu, delta, and kappa found in 
NMB cells. Therefore, to block mu and delta receptor binding, 1 J.1M ofDAMGO and DADLE 
were also included in every reaction. In Figure 5, the results indicated that the 48 hour treated 
group showed a significant increase (around 2-fold), however, the 24 hour treatment did not 
result in a significant increase as compared to the control group, suggesting that there is a lag 
between the changes of mRNA level and the changes of protein level. Overall, this data 
suggested that hKOR protein level is significantly increased at 48 hours ofDFO treatment. 
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Plasmid Construction of bKOR promoter region: 
To further investigate if the HIF-I is involved in the increase ofhKOR mRNA level in 
this cell model system, the luciferase reporter assay was chosen. First the plasmid construction 
was performed by cloning the putative HIF responsive elements of the hKOR promoter region 
into pGL3-promoter vector. There are a total of4 putative HIP responsive elements in the 5' 
flanking region ofhKOR gene, which are designated as A (the far one from the gene), B, C and 
D (The closest one). Each of these DNA fragments containing the putative HIF response 
elements was generated by PCR method. The PCR products were then cloned into pCR2.1 vector 
(Fig. 6A). The E. coli competent cells were then transformed using the ligation mixture with 
heat-shock method. The transformed bacteria were then selected under the ampicillin containing 
plates. The plasmid was then purified from the individual colony, and each plasmid was verified 
by restriction enzymes digestion. Each digested sample was then examined using 2% agarose gel 
to check for the presence ofthe cloned insert. 
The clones with the insert were then subjected to DNA sequencing. An insert with the 
correct sequence was then sub-cloned into pGL3-promoter vector (Fig. 6B), which contains the 
luciferase reporter gene. The similar screening processes for various clones were used (as 
described above). Figure 7 A, shows a representative gel screening of clone A, Fig 7B for clone 
B, 7C for clone C, and 7D for clone D. The plasmids contained the inserts were subjected to 
sequencing again. The plasm ids with the correct sequences were then subjected to large scale 
plasmid purification. 
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Examining the function of putative HIF-l responsive elements using the luciferase reporter 
assay 
To detennine the functional role of these putative HIF responsive elements, NMB cells 
were transiently transfected with the pGL3 promoter-Iuciferase reporter gene and HIF expression 
vector. Each set contained a negative control plasmid, a blank pGL-3 promoter vector (P). After 
transfection, cells were treated with DFO for 24 hours. The cells were then harvested and lysed. 
The luciferase activity was then detennined. 
The preliminary data from the luciferase assay (Fig. 8) showed that A and C had a slight 
increase and B show no difference ofluciferase activity after 24 hours ofDFO treatment. 
However, D showed the strongest increase in expression among the 4 putative elements. The 
result indicated that A, C, and D regions increase in expression after 24 hours ofDFO treatment. 
In addition, we also obtained a clone plasmid containing 2 copies ofHIF responsive 
element D (2-D). The luciferase activity of this plasmid was also examined using the same 
procedure as previously described. Fig. 9 showed that the 2-D plasmid had a very strong 
response under the treatment indicating that HIF responsive element in the D region may play an 
important role under hypoxic condition. 
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Figure 5: NMB cells were treated without or with DFO for 24 and 48 hours. Membranes were 
prepared and used for radioisotope-ligand binding. Each sample had the same amount of protein. 
The data is expressed as mean ± standard error. (n=3) '" indicates p<O.OOI 
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Figure 6: Cloning of the region of interest. A. pCR2.1 Vector was used to clone the regions of 
interest (adapted from Lablife), and B. then sub-cloned into pGL3-promoter with luciferase 
reporter gene (adapted from Promega). 
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Figure 7: Gel analysis ofconstructs. There are 4 putative HIF responses elements ofhKOR 
promoter region. There are designated as A (farthest from the promoter), B, C and D (closest to 
the promoter).Each plasmid was digested overnight with Xhol and Asp7I8, and then ran on 2% 
agarose gel. The plasmids with appropriate size were sequenced for the correct insert. 
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Luciferase Acitivity 
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Figure 8: Preliminary resutls of luciferase acitivity of putative HIF response elements. NMB 
cells were plated in 6 well plates, and each group of the cells was transiently transfected with the 
plamsids containg the HIF putuative response elements ofhKOR promoter region. Pan emptry 
vector (negative control), A (fartherst from the promoter region) B, C, and D (closest to the 
promoter). Cells were analyzed 24 hours after DFO treatment, and luciferase acitivity was 
measured. 
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Figure 9: Prelimanry resutls ofluciferase analysis of 2-D insert. The cells were treated with 2-D 
insert, and treated with DFO for 24 hours. Luciferase analysis was conducted and this is a 
representative data of the result. 
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Discussion 

The aim of this study was first to investigate the change ofopioid receptor protein levels 
under hypoxia, and secondly to examine ifHIF mediated the mRNA change ofhKOR level in 
NMB hypoxic cell model system. This study showed that hKOR protein levels increased at the 
48 hour treatment and HIF mediated the increase ofhKOR expression in this hypoxic cell model 
system. 
The increase ofhKOR mRNA level was detected after 24 hours ofDFO treatment (Karch 
et aI., unpublished data). However, the change ofhKOR protein level was not detectable at 24 
hour treatment using the receptor-ligand binding assay, although there was about 2-fold increase 
at the 48 hour treatment. One of the possibilities is the limitation ofboth protein and mRNA 
experiments, therefore proper correlation is not observed 
An increase ofhKOR expression was shown in this study, but do they offer 
neruoprotection in hypoxic condition? There are reports that have shown that hKOR offers 
neuroprotection in hypoxic conditions (Schunk et aI., 2011~ Zeynalov et aI., 2000). It has been 
shown that the treatment with KOR agonist BRL 52537 provides a long therapeutic window 
against ischemia in rats (Zeynalov et aI., 2006). As well as in mice brain, preconditioning with 
KOR agonist U-69593 has offered protection against seizures, furthermore, using a KOR 
antagonist nor-BNI did block the protection indicating that activation ofKOR may mediate 
neuroprotective effect (Rubaj et aI., 2000)). However, there are also opposite reports, in a study 
using ischemic rats~ KOR did not offer any neuroprotection (Zhang et aI., 2000). Whether KOR 
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can provide neuroprotection against hypoxia in this NMB cell model system, will be examined in 
the near future. 
HIF-I is a transcriptional regulator ofhypoxia (Ke et aI., 2006). Our preliminary results 
using the luciferase reporter assay showed that several HIF response regions of the hKOR gene 
were involved in the increase of hKOR transcription under DFO simulated hypoxia. The plasmid 
containing two copies ofD (2-D) showed an extremely strong reporter activity, suggesting that 2 
copies of the D region are acting synergistically. In summary, this study suggested that HIF may 
play an important role in the upregulation ofhKOR message. However, we will need to repeat 
these experiments to confirm these preliminary results in the near future. 
HIF-I has many target genes; the most interesting would be the TGF and IGF genes 
which are linked to cell proliferation and survival (Semenza et aI., 2003). IGF-I has been shown 
to mediate neuroprotection in embryonic rat neurons, and prevents neuronal programmed cell 
death (Vincent et aI., 2010). As stated before, the increase in glutamate in the neuronal cells 
causes cell death (Dendorfer et aI., 2005). TGF-p has been able to protect hippocampal neurons 
in vitro against short term exposure from glutamate (Alzheimer et aI., 2002). In addition, this 
study also provided evidence and suggested that hKOR is a HIF target gene. 
This study indicates that hKOR may play an important role in hypoxic condition using 
hypoxic NMB cells model. Future experiments include the blocking ofHIF-1 with siRNA 
strategy to observe if the downregulation ofHIF will affect hKOR expression, and examining the 
downstream effect of opioid receptors will be useful. It is also interesting to understand the 
combinatory effect ofputative HIF response elements on the expression of hKOR, which will 
provide further information about the adaptive responses ofhuman neuronaI cells under hypoxic 
simulated condition. 
24 
Conclusion 
Using the human hypoxic neuronal cell model system we found that the treatment with 
DFO, a hypoxic mimicking compound, resulted in an increase ofIDF·l rnRNA levels in the 
surviving cells. Also, there were various influences on the expression of different opioid receptor 
genes under hypoxia. The 24 hour treatment caused the decrease ofhMOR message level in the 
surviving cells, but the hDOR expression showed no significant change. However, the hKOR 
message increased in this hypoxic model system. 
This study further demonstrated that not only that hKOR rnRNA level increased, but also 
the expression ofhKOR protein increased significantly at 48 hour of treatment as compared to 
control and the 24 hour treatment, which can be due to the translational regulation and protein 
abundance. In addition, the preliminary results from the luciferase reporter assay suggested that 
the 5' flanking regions of the KOR gene containing the functional HIF responsive elements, 
which can playa role in hypoxia. Furthermore, the plasmid containing 2 copies ofHIF 
responsive element of the D region showed an extremely strong activity, suggesting that D 
region has an important role in hKOR regulation under hypoxia. Further studies, such as the 
investigation ofcombinatory effect ofHIF responsive elements and signaling pathways 
controlling the downstream effect under hypoxia, will provide the useful information to help us 
understand the cellular adaptive response under hypoxia. 
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